Isoprostanes 8-iPF2α-III: Risk markers of premature rupture of fetal membranes?

Biomarkers

Volumn 14, Issue 6, 2009, Pages 406-413

  Kwiatkowski, Sebastian ^a   Torbé, Andrzej ^a   Dołgowska, Barbara ^a   Błogowski, Wojciech ^a   Czajka, Ryszard ^a   Chlubek, Dariusz ^a   Rzepka, Rafał ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Isoprostane; Oxidative stress; Premature rupture of membranes

Indexed keywords

ISOPROSTANE DERIVATIVE; BIOLOGICAL MARKER; ISOPROSTANE F2ALPHA III;

ADOLESCENT; ADULT; AMNION FLUID; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL PLASMA; PLASMA; PREGNANCY; PREMATURE FETUS MEMBRANE RUPTURE; BLOOD; CASE CONTROL STUDY; CHEMISTRY; DIAGNOSIS, MEASUREMENT AND ANALYSIS; GESTATIONAL AGE; OXIDATIVE STRESS; RISK FACTOR;

ADULT; AMNIOTIC FLUID; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; GESTATIONAL AGE; HUMANS; ISOPROSTANES; LABORATORY TECHNIQUES AND PROCEDURES; OXIDATIVE STRESS; PREGNANCY; RISK FACTORS;

EID: 70849111559     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500903045583     Document Type: Article

References (43)

1. Allen RG, Tresini M. (2000). Oxidative stress and gene regulation. Free Radic Biol Med 28:463-499
2. Barden A, Beilin LJ, Ritchie J, Croft KD, Walters BN, Michael CA. (1996). Plasma and urinary 8-iso-prostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy. Clin Sci 91:711-718
3. Basu S. (2004). Isoprostanes: novel bioactive products of lipid peroxidation. Free Radic Res 38:105-122
4. Bengtson JM, VanMarter LJ, Barss VA, Greene MF, Tuomala RE, Epstein MF. (1989). Pregnancy outcome after premature rupture of the membranes at or before 26 weeks' gestation. Obstet Gynecol 73:921-927
5. Blackwell TS, Christman JW. (1997). The role of nuclear factor-B in cytokine gene regulation. Am J Respir Cell Mol Biol 17:3-9.
6. Brant KA, Caruso RL. (2006). PCB 50 stimulates release of arachidonic acid and prostaglandins from late gestation rat amnion fibroblast cells. Reprod Toxicol 22:591-598
7. Comporti M, Signorini C, Leoncini S, Buonocore G, Rossi V, Ciccoli L. (2004). Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age. Free Radic Biol Med 37:724-732
8. Dolegowska B, Stepniewska J, Ciechanowski K, Safronow B, Millo B, Bober J, Chlubek D. (2007). Does glucose in dialysis fluid protect erythrocytes in patients with chronic renal failure? Blood Purification 25:422-429
9. Fukunaga M, Makita M, Roberts LJ, Morrow JD, Takahashi K, Badr KF. (1993). Evidence for the existance of the F2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol 264:1619-1624
10. Hansen WR, Keelan JA, Skinner SJ, Mitchell MD. (1999). Key enzymes of prostaglandin biosynthesis and metabolism. Coordinate regulation of expression by cytokines in gestational tissues: a review. Prostagland Other Lipid Mediat 57:243-257
11. Ikekuchi Y, Masumoto N, Tasaka K, Koike K, Kasahara K, Miyake A, Tanizawa O. (1991). Superoxide anion increases intracellular pH, intracellular free calcium and arachidonate release in human amnion cells. J Biol Chem 266:13233-13237
12. Jaulmes A, Thierry S, Janvier B, Raymondjean M. Marechal V. (2006). Activation of sPLA2-IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-1beta. FASEB J 20:1727-1729
13. Kataoka S, Furuta I, Yamada H, Kato EH, Ebina Y, Kishida T, Kobayashi N, Fujimoto S. (2002). Increased apoptosis of human fetal membranes in rupture of the membranes and chorioamnionitis. Placenta 23:224-231
14. Kilbride HW, Yeast J, Thibeault DW. (1996). Defining limits of survival: lethal pulmonary hypoplasia after midtrimester premature rupture of membranes. Am J Obstet Gynecol 175:675-681
15. Kudo I, Murakami M. (2002). Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat 68-69:3-58.
16. Kunapuli P, Lawson JA, Rokach JA, Meinkoth JL, FitzGerald GA. (1998). Prostaglandin F2? (PGF2?) and the isoprostane, 8,12- iso-isoprostane F2?-III, induce cardiomyocyte hypertrophy. J Biol Chem 273:22442-22452
17. Kuroda M, Kaminishi T, Uchida K, Miyazawa K, Tomoike H, Doi K. (1995). Ca2+ increase and pH decrease induced by hypochlorous acid in single quiescent myocytes isolated from rat ventricles. Japanese J Physiol 45:619-630
18. Little RE, Gladen BC. (1999). Levels of lipid peroxides in uncomplicated pregnancy: a review of the literature. Reprod Toxicol 13: 347-352.
19. Longini M, Perrone S, Vezzosi P, Marzocchi B, Kenanidis A, Centini G, Rosignoli L, Buonocore G. (2007). Association between oxidative stress in pregnancy and preterm premature rupture of membranes. Clin Biochem 40:793-797
20. Makino A, Skelton MM, Zou., AP, Roman RJ, Colwey AW Jr. (2002). Increased renal medullary oxidative stress produces hypertension. Hypertension 39:667-672
21. McCaul JF, Rogers LW, Perry KG Jr, Martin RW, Allbert JR, Morrison JC. (1997). Premature rupture of membranes at term with an unfavorable cervix: Comparison of expectant management, vaginal prostaglandin, and oxytocin induction. Southern Med J 80:1229-1233
22. Menon R, Lombardi SJ, Fortunato SJ. (2001). IL-18, a product of choriodecidual cells, increases during premature rupture of membranes but fails to turn on the Fas-FasL-mediated apoptosis pathway. J Assist Reprod Genet 18:276-284
23. Minuz P, Andrioli G, Degan M, Gaino S, Ortolani R, Tommasoli R, Zuliani V, Lechi A, Lechi C. (1998). The F2-isoprostane 8- epiprostaglandin F2? increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO. Arterioscler Thromb Vasc Biol 18:1248-1256
24. Monboisse JC, Braquet P, Randoux A, Borel JP. (1993). Non-enzymatic degradation of acid-soluble calf skin collagen by superoxidation: protective effect of flavonoids. Biochem Pharmacol 32:53-58
25. Morrow J, Awad JA, Boss HJ, Blair IA, Roberts LJ. (1992). Noncyclooxygenase- derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA 89:10721-10725
26. Morrow J, Roberts J. (1997). The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 36:1-21.
27. Morrow J, Zackert W, Yang J, Kurhts EH, Callewaert D, Dworski R, Kanai K, Taber D, Moore K, Oates JA, Roberts LJ. (1999). Quantification of the major urinary metabolite of 15- F2t-isoprostane (8-iso- PGF2alpha) by a stable isotope dilution mass spectrometric assay. Anal Biochem 269:326-331
28. Morrow ID, Roberts II LJ. (1999). Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Meth Enzymol 300:3-12.
29. Panasenko DM, Evgina SA, Dviomino ES, Sharov VS, Sergienko VI, Vladimirov TA. (1995). Hypochlorite induces lipid peroxidation in blood lipoproteins and phospholipid liposomes. Free Radic Biol Med 19:133-140
30. Pratico D, Iuliano L, Mauriello A, Spagnoli L, Lawson JA, Maclouf J, Violi F, FitzGerald GA. (1997). Localization of distinct F2- isoprostanes in human atherosclerosis lesions. J Clin Invest 100:2028-2034
31. Roberts II LJ, Morrow JD. (2000). Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 28:505-513
32. Rokach J, Khanapure SP, Hwang SW, Adiyaman M, Lawson JA, FitzGerald GA. (1997). Nomenclature of isoprostanes: a proposal. Prostaglandins 54:853-873
33. Romero JC, Reckelhoff JF. (2000). Oxidative stress may explain how hypertension is maintained by normal levels of angiotensin II. Brazilian J Med Biol Res 33:653-660
34. Rotschild A, Ling EW, Puterman ML, Farquharson D. 1990. Neonatal outcome after prolonged preterm rupture of the membranes. Am J Obstet Gynecol 162:46-52.
35. Sagol S, Sagol O, Ozkal S. Asena U. (2002). Role of apoptosis, bcl-2 and bax protein expression in premature rupture of fetal membranes. J Reprod Med 47:809-815
36. Shubert PJ, Diss E, Iams JD. (1992). Etiology of preterm premature rupture of membranes. Obstet Gynecol Clin N Am 19:251-263
37. Sibille Y, Lwebuga-Mukasa JS., Polomski L, Merrill WW, Ingbar DH, Gee JBL. (1986). An in vitro model for polymorphonuclear leukocyte- induced injury to an extracellular matrix. Relative contribution of oxidants and elastase to fibronectin release from amnionic membranes. Am Rev Respir Dis 134:134-140
38. Staff AC, Ranheim T, Halvorsen B. (2003). Augmented PLA2 activity in pre-eclamptic decidual tissue - a key player in the pathophysiology of 'acute atherosis' in pre-eclampsia? Placenta 24:965-973
39. Tak PP, Firestein GS. (2001). NF-kappaB: a key role in inflammatory diseases. J Clin Invest 107:7-11.
40. Takahashi K, Nammour TM, Fukunaga M, Ebert J, Morrow JD, Roberts LJD, Hoover RL, Badr KF. (1992). Glomerular actions of a free-radical generated novel prostaglandin, 8-epi-prostaglandin F2? in the rat: Evidence for interaction with thromboxane A2 receptors. J Clin Invest 90:136-141
41. Wang Z, Ciabattoni G, Creminon C, Lawson J, Fitzgerald GA, Patrono C, Maclouf J. (1995). Immunological characterization of urinary 8-epi-prostaglandin F2? excretion in man. J Pharmacol Exp Ther 275:94-100.
42. Winterbourn CC, Essman WB. (1990). Neutrophil oxidants: production and reactions. In: Das DK, Essman WB, eds. Oxygen radicals: Systemic Events and Disease Processes. New York: Karger, 1990. p. 31-70.
43. Wiswedel I, Hirsch D, Carluccio F, Hampl H, Siems W. (2005). F2- Isoprostanes as biomarkers of lipid peroxidation in patients with chronic renal failure. Biofactors 24:201-208